产前非整倍体筛查与一线无创产前检测的社会人口学差异:一项多中心队列研究
在澳大利亚墨尔本11家公立医院开展回顾性多中心研究,纳入2022—2024年分娩且孕周≥20周的孕妇,分析非整倍体筛查的接受率和方式。在80,355名有筛查数据的孕妇中,82.6%接受了筛查,无创产前检测(NIPT)占80.6%;NIPT接受率从最弱势地区的75.3%升至最有优势地区的88.9%,校正后仍与社会经济优势相关(aIRR 1.09,95%CI 1.06-1.13)。
要点
- 在102,729名孕妇中,80,355名(78.2%)有筛查数据,其中66,343名(82.6%)接受了非整倍体筛查。
- 接受筛查者中NIPT占80.6%(n=53,475),早孕期联合筛查占16.6%(n=10,991),中孕期血清筛查占2.5%(n=1,634)。
- NIPT接受率与地区社会经济优势相关:最有优势地区为88.9%,最弱势地区为75.3%,校正后aIRR为1.09(95%CI 1.06-1.13)。
核心结论
- NIPT是主要的筛查方式,但其接受率与社会经济优势密切相关,提示澳大利亚最准确的非整倍体筛查方法的接受率存在差异。
研究设计与样本
- 回顾性多中心队列研究,纳入2022—2024年澳大利亚墨尔本11家公立医院分娩且孕周≥20周的孕妇,从常规产科医院数据库收集孕产妇和妊娠协变量。
主要发现
- 在102,729名孕妇中,80,355名(78.2%)有筛查数据;66,343名(82.6%)接受了非整倍体筛查,12,632名(15.7%)拒绝筛查,1,380名(1.7%)未被提供筛查。
- 拒绝筛查的孕妇更可能较年轻(<30岁)、经产或来自特定地区的移民。
- 在接受筛查的孕妇中,NIPT占80.6%(n=53,475),早孕期联合筛查占16.6%(n=10,991),中孕期血清筛查占2.5%(n=1,634)。
- NIPT接受率从最弱势地区的75.3%上升至最有优势地区的88.9%,校正后仍与社会经济优势相关(最有优势地区 vs 最弱势地区:aIRR 1.09,95%CI 1.06-1.13)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine prenatal aneuploidy screening uptake and modality in a high-income setting where non-invasive prenatal testing (NIPT) is recommended but remains self-funded, and to investigate variation by sociodemographic and clinical characteristics. METHOD: We conducted a retrospective multi-centre study of women who gave birth at ≥ 20 weeks' gestation across 11 public hospitals in Melbourne, Australia from 2022-2024. Maternity and pregnancy covariates were collected from routine maternity hospital databases. RESULT: Of 102,729 women, screening data were available for 80,355 (78.2%); 66,343 (82.6%) had aneuploidy screening, 12,632 (15.7%) declined, and 1380 (1.7%) were not offered screening. Women who declined screening were more likely to be younger (< 30 years), multiparous, or migrants from specific regions. Among screened women, NIPT was the predominant modality (80.6%, n = 53,475), followed by combined first trimester screening (16.6%, n = 10,991) and second trimester serum screening (2.5%, n = 1634). NIPT uptake increased from 75.3% in the most disadvantaged regions to 88.9% in the most advantaged regions and remained associated with socioeconomic advantage after adjustment (aIRR 1.09, 95% CI 1.06-1.13 for most advantaged vs. most disadvantaged regions). CONCLUSION: NIPT was the predominant screening modality; however, its uptake was strongly associated with socioeconomic advantage, suggesting variation in uptake of the most accurate aneuploidy screening test in Australia.
引用
- Pynaker C, Marzan M, Lewis S, et al. Sociodemographic Variation in Prenatal Aneuploidy Screening and First-Line Non-Invasive Prenatal Testing: A Multicentre Cohort Study. Prenat Diagn. 2026. PMID: 43013874. doi:10.1002/pd.70303
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。